Stacey Bain
Impact in
- Dermatology top 5%
- Chemotherapy-related skin toxicity
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 2
-
- Chemotherapy-related skin toxicity 2
- Co-authors
- Frederick H. Hausheer (3 shared papers)Richard L. Schilsky (1 shared paper)Frank S. Lieberman (1 shared paper)Elmer Berghorn (1 shared paper)Anne‐Claire Hardy‐Bessard (1 shared paper)D. Paraïso (1 shared paper)Sophie Camilleri‐Broët (1 shared paper)Bernard Leduc (1 shared paper)
- Journals
- Clinical Pharmacokinetics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Seminars in Oncology (1 paper)Annals of Oncology (1 paper)Japanese Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Stacey Bain
7 papers receiving 454 citations
Peers
Comparison fields: 5 of 66
- Dermatology 148
- Oncology 371
- Hematology 89
- Anesthesiology and Pain Medicine 26
- Reproductive Medicine 39
Countries citing papers authored by Stacey Bain
This map shows the geographic impact of Stacey Bain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Bain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Bain more than expected).
Fields of papers citing papers by Stacey Bain
This network shows the impact of papers produced by Stacey Bain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Bain. The network helps show where Stacey Bain may publish in the future.
Co-authors
The 25 scholars most cited alongside Stacey Bain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 307 | |
| 2 | 2003 | 80 | |
| 3 | 2008 | 31 | |
| 4 | 2000 | 25 | |
| 5 | 2003 | 25 | |
| 6 | Comprehensive meta-analysis of survival outcomes from two randomized multicenter trials in first-line advanced non-small cell lung cancer in patients treated with the novel investigational antitumor-enhancing and chemoprotective agent Tavocept | 2010 | 5 |
| 7 | 2006 | 4 |
About Stacey Bain
Stacey Bain is a scholar working on Oncology, Dermatology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Pharmacology, having authored 7 papers that have together received 477 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Computational Drug Discovery Methods (2 papers), Chemotherapy-related skin toxicity (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Nanoplatforms for cancer theranostics (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Cancer therapeutics and mechanisms (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Dermatology (148 citations), Oncology (371 citations), Hematology (89 citations), Anesthesiology and Pain Medicine (26 citations) and Reproductive Medicine (39 citations). Stacey Bain has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Frederick H. Hausheer, Richard L. Schilsky, Frank S. Lieberman, Elmer Berghorn, Anne‐Claire Hardy‐Bessard, D. Paraïso, Sophie Camilleri‐Broët, Bernard Leduc, A. Le Tourneau and Josée Audouin. Their work appears in journals such as Clinical Pharmacokinetics, Cancer Chemotherapy and Pharmacology, Seminars in Oncology, Annals of Oncology and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.